BernaL., CarrioI., AlonsoC., FerrèJ., EstorchM., TorresG.: Bone pain palliation with strontium-89 in breast cancer patients with bone metastases and refractory bone pain. Eur. J. Nucl. Med., 22: 1101–1104, 1995
2.
BlakeG.M., ZivanovicM.A., McEwanA.J., AckeryD.M.: Sr89 therapy: strontium kinetics in disseminated carcinoma of the prostate. Eur. J. Nucl. Med., 12: 447–454, 1986.
3.
De AgostiniA., MascaraL., PizzocaroC., PanarottoM.B., BestagnoM.: 85Sr contaminant as a reliable tracer of 89Sr for monitoring urinary radioactivity in patients treated with 89Sr for bone metastases. J. Nucl. Biol. Med., 37: 38–44, 1993.
4.
DearnaleyD.P., BaylyR.J., A'HernR.P., GaddJ., ZivanovicM.A., LewingtonV.J.: Palliation of bone metastases in prostate cancer. Hemibody irradiation or strontium 89? Clin. Oncol., 4: 101–107, 1992.
5.
LaingA.H., AckeryD.M., BaylyR.J., BuchananR.B., LewingtonV.J., McEwanJ.B., MacleodP.M., ZivanovicM.A.: Strontium-89 chloride for pain palliation in prostatic skeletal malignancy. Br. J. Rad., 64: 816–822, 1991.
6.
LewingtonV.J., McEwanA.J., AckeryD.M., BaylyR.J., KeelingD.H., MacleodP.M., PorterA.T., ZivanovicM.A.: A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone. Eur. J. Cancer, 27: 954–958, 1991.
7.
PorterA.T., McEwanA.J.: Strontium-89 as an adjuvant to external beam radiation improves pain relief and delays disease progression in advanced prostate cancer: results of a randomized controlled trial. Sem. Oncol., 20 (Suppl. 2): 38–43, 1993.
8.
RobinsonR.G., SpicerJ.A., PrestonD.F., WegstA.V., MartinN.L.: Treatment of metastatic bone pain with strontium-89. Nucl. Med. Biol., 14: 219–222, 1987.
9.
RobinsonR.G., PrestonD.F., SchiefelbeinM., KirkmanG.B.: Strontium 89 therapy for the palliation of pain due to osseous metastases. JAMA, 274: 420–424, 1995.
